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http://dx.doi.org/10.1016/j.pedneo.2A female newborn was admitted to our department 15 days after birth for insufficient sucking
and jaundice. The patient’s blood and urine cultures were both positive for group B strepto-
coccal (GBS) infection. A maternal vaginal sample at 35 weeks’ gestation was negative for
GBS in culture-based microbiologic screening. The patient recovered shortly after receiving
systemic antibiotic therapy. On the basis of clinical evidence of white stool and progressive
jaundice, we suspected that the newborn had complications related to congenital biliary
atresia (CBA); surgery was performed. Isolates from the mother’s vaginal sample obtained
when the patient was 25 days old, along with neonatal blood, revealed identical patterns
(serotype VIII and sequence type 1) of GBS capsular and multilocus sequence typing, suggestive
of maternal transmission. Molecular epidemiologic examination may be useful to clarify the
transmission route and etiology; culture-based microbiologic screening appears to have limita-
tions for detecting the route of transmission.
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treated empirically with combined parenteral antibioticsGroup B streptococcus (GBS, Streptococcus agalactiae) is
a major contributor to invasive infections, such as menin-
gitis and sepsis, in newborns and infants. These infections
were classified as early onset (from birth to Day 6) or late
onset (from Days 7 to 89). The GBS that causes early-onset
infection is usually transmitted from mother to newborn,
and late-onset infection is usually transmitted via either
horizontal or vertical routes. In Japan, the 2008 obstetric
guidelines recommend culture-based microbiologic
screening for all pregnant women during weeks 33e37 of
gestation.1 However, because of low screening sensitivity,
cases of invasive GBS infection have developed despite
negative screening results.2
GBS serotypes isolated from children with invasive
infections differ from those in adults. In descending order,
serotypes III, Ia, and Ib are predominant among children,
whereas serotype VIII is a rare type that is detected by
polymerase chain reaction (PCR) assay.3 Multilocus
sequence typing is a molecular epidemiologic method used
to evaluate the clonality of GBS strains.4
We herein report a late-onset serotype VIII GBS infection
via vertical transmission with a negative antenatal
maternal screening in a neonate having congenital biliary
atresia (CBA).
2. Case Report
The affected neonate was a female weighing 2650 g when
born at 39 weeks’ gestation by vaginal delivery to a 35-
year-old primigravida. A maternal vaginal sample obtained
at 35 weeks’ gestation was negative for GBS according to
culture-based microbiologic screening. Neither preterm
complications nor prolonged rupture of maternal
membranes had occurred. No abnormalities of the placenta
or umbilical cord were observed. The Apgar score was 8 at 1
minute and 9 at 5 minutes. At 4 days of age, the newborn
received 2 days of phototherapy for idiopathic neonatal
jaundice. The infant was discharged at 6 days of age. At 13
days of age, the infant suddenly became unwell, exhibiting
insufficient sucking and a pale face. At 15 days of age, the
infant remained unwell and the mother brought her
daughter to our department. The neonate was hospitalized
immediately.
Upon admission, physical examination revealed fever
(37.1C), a pale face with peripheral cyanosis, and irregular
respiration with apnea. Her percutaneous saturation of
oxygen under room air was unstable (less than 90%), and
neither inspiratory crackles nor expiratory rhonchi were
apparent upon auscultation. Laboratory findings indicated
normal levels of white blood cells (17,400 /mL), platelets
(458,000 /mL), and blood glucose (93 mg/dL), as well as
elevatedconcentrations of serumC-reactiveprotein (2.0mg/
dL), total and direct bilirubin (10.6 mg/dL and 4.17 mg/dL),
and g-GTP (877 IU/L). Examination of the cerebrospinal fluid
(CSF) revealed mild increases in cell counts (61/mL) and no
decrease in glucose (35 mg/dL). The patient showed no
abnormalities in serum immunoglobulins.
GBS was cultured from blood and urine, but not from the
CSF or nasopharyngeal specimens. These findings suggestedGBS infection and cholestasis. Thus, the patient was
(ampicillin 120e200 mg/kg/day and ceftriaxone 60 mg/kg/
day), along with supportive management, which included
an oxygen supplement. The patient’s general condition and
laboratory results improved rapidly. Following this therapy,
the infant was observed to have white-colored stools and
progressive jaundice. An abdominal ultrasound revealed no
evidence of gallbladder or biliary tract abnormalities. The
patient was referred to the department of pediatric surgery
in a different specialized hospital, where she was examined
for CBA. At 23 days of age, the patient underwent surgery
and intrahepatic CBA was diagnosed. Following surgery, and
despite 1 month of steroid therapy to prevent cirrhosis of
the liver, GBS infection did not recur. At a follow-up
assessment 10 months later, the patient exhibited no
neurologic sequelae.
When the patient was 25 days of age, written consent
was obtained to collect breast milk, a vaginal swab, and an
anal swab from the mother to evaluate the route of
transmission. These specimens, along with the GBS isolate
from the neonatal blood, were sent to the Laboratory of
Molecular Epidemiology for Infectious Agents at Kitasato
Institute for Life Sciences, Kitasato University, to identify
the species and its molecular epidemiology. Real-time PCR,
amplifying the GBS-specific dltS gene, was used as previ-
ously described.3 Real-time PCR of the vaginal sample
revealed dltS amplification. GBS was also cultured out of
the vaginal sample. However, no pathogens were detected
from the anal and breast milk cultures.
We determined the capsular type and multilocus
sequence typing for both GBS isolates from the mother’s
vagina as well as from the child’s bloodstream. These
examinations indicated that both isolates were identical
(serotype VIII and sequence type 1). Additionally, no GBS
was identified during routine surveillance for newborns in
the neonatal intensive care unit (NICU) using nasopharyn-
geal swabs, or from standard cultures on samples from
children and pregnant women in the same pediatrics and
obstetrics ward 1 month before and after this patient’s
admission.
Table 1 presents microbiologic GBS screening data from
pregnant women in our hospital collected during the past 5
years (from April 2006 to March 2011). Of the 1930 cases
analyzed at 34e35 weeks’ gestation, 72 (3.7%) were posi-
tive according to the screening results. Unfortunately, two
cases of GBS infection developed following negative
screening results. Early-onset GBS sepsis was diagnosed in
a patient with progressive respiratory distress, and she
manifested no neurologic sequelae after discharge. The
other case was the late-onset infection described here.3. Discussion
The GBS infection described here was late onset and caused
by serotype VIII in a neonate with CBA. The primary
symptoms of early-onset infections tend to include
progressive respiratory distress, whereas symptoms of late-
onset infections include insufficient sucking, low activity,
and other indicators of unwellness. Sepsis accounts for
44.1% of the cases of late-onset infections, and meningitis
Table 1 Results of antenatal maternal culture-based screening using vaginal swab specimens during the 5-year period (from
April 2006 to March 2011).
Apr 2006 to
Mar 2007
Apr 2007 to
Mar 2008
Apr 2008 to
Mar 2009
Apr 2009 to
Mar 2010
Apr 2010 to
Mar 2011
Total five years
Negative 395* 412 422 444 185* 1858
Positive 13 10 16 25 8 72
Total 408 422 438 469 193 1930
Positive rate (%) 3.2 2.4 3.7 5.3 4.1 3.7
Seventy-two of 1930 cases (3.7%) had positive results from screening. Asterisks denote two cases of invasive group B streptococcal
infection and the negative screening.
Late onset GBS infection with serotype VIII 65accounts for 40.9%.5 Accordingly, our neonate proceeded
through a typical clinical course. Invasive GBS infection
caused by serotype VIII was first reported in 1990.5 In
Japan, the most prevalent invasive GBS strain in infants was
type III for both early- and late-onset infections. Type VIII
strains were detected in 14 of 258 isolates (5.4%) from
early- onset disease and in one of 73 isolates (1.4%) from
late-onset disease.6 Type VIII strains were reported to
possess some degree of virulence in neonates, producing
clinical symptoms (e.g., progressive respiratory distress)
similar to those associated with early-onset infection in
other common strains.7 The clinical syndromes presented in
this patient were bacteremia and urinary tract infection,
similar to those presented in adults with GBS infection and
underlying medical conditions. To our knowledge, this is
the first report to describe late-onset type VIII GBS infec-
tion with congenital abnormality.
Because 95% of these patients presented symptoms
within 2 days of birth, early- onset infection is believed to
be transmitted by a vertical route. Transmission of late-
onset infection seems to occur by both vertical and hori-
zontal routes. Confirmed cases of horizontal transmission
have occurred via breast milk.8 Several reports have also
correctly estimated the outbreak of late-onset infections in
the same room and department.9,10 However, no pathogens
were detected from a culture of breast milk from this
patient’s mother. Nor was GBS identified during routine
surveillance for newborns in the NICU using nasopharyngeal
swabs, or from standard cultures on samples from children
and pregnant women in the same pediatrics and obstetrics
ward 1 month before or after this patient’s admission.
These results suggest vertical rather than horizontal
transmission. Identical GBS strains, as determined by
capsular typing and multilocus sequence typing (sequence
type 1), were isolated from the mother’s vagina and the
child’s blood. This finding also supports vertical
transmission.
The maternal screening test for GBS was negative for
both cases of neonatal GBS infections in the current report.
These observations suggest that culture-based microbio-
logic screening is limited in its capability to detect colo-
nized GBS at delivery. A novel approach is needed to
improve sensitivity in order to identify GBS colonization.
Vaginal colonization at delivery may differ from coloniza-
tion during pregnancy because the vaginal pH undergoes
significant changes. The PCR assay is a novel method to use
instead of the culture.11 A multiplex real-time PCR assayappears useful for the rapid detection of virulent GBS, and
it is a novel antenatal screening method. Clinical trials
need to be conducted to assess the efficacy and the costs
versus benefits of the PCR assay for future use.
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